APA (7th ed.) Citation

Li, Y., Wang, T., Shen, M., Fu, R., Gao, X., Wu, S., . . . Li, S. (2026). Syringin Protects Against Doxorubicin‐Induced Cardiotoxicity via Apelinr‐Dependent Activation of the Nuclear Factor‐Erythroid 2‐Related Factor 2/Heme Oxygenase‐1 Antioxidant Pathway. Wiley. https://doi.org/10.1002/ptr.70312

Chicago Style (17th ed.) Citation

Li, Yujiang, et al. Syringin Protects Against Doxorubicin‐Induced Cardiotoxicity via Apelinr‐Dependent Activation of the Nuclear Factor‐Erythroid 2‐Related Factor 2/Heme Oxygenase‐1 Antioxidant Pathway. Wiley, 2026. https://doi.org/10.1002/ptr.70312.

MLA (9th ed.) Citation

Li, Yujiang, et al. Syringin Protects Against Doxorubicin‐Induced Cardiotoxicity via Apelinr‐Dependent Activation of the Nuclear Factor‐Erythroid 2‐Related Factor 2/Heme Oxygenase‐1 Antioxidant Pathway. Wiley, 2026. https://doi.org/10.1002/ptr.70312.